| Website | chimerix-inc.com |
| Category | BioTech |
| Employees | |
| Founded | 2002 |
| Description | Antiviral Therapeutics Developer |
| Total | $27.1M |
| Series C, 11/04 Frazier Technology Ventures Sanderling Ventures Asset Management Company | $11M |
| Series E, 8/09 Canaan Partners Alta Partners Sanderling Ventures Asset Management Company | $16.1M |
Chimerix discovers, develops and commercializes antiviral therapeutics with enhanced pharmaceutical properties for the treatment of a range of life-threatening diseases.